Incorporation of photo-carbon monoxide releasing materials into electrospun scaffolds for vascular tissue engineering

被引:18
作者
Michael, Eden [1 ]
Abeyrathna, Nawodi [2 ]
Patel, Aatish V. [3 ]
Liao, Yi [2 ]
Bashur, Chris A. [1 ]
机构
[1] Florida Inst Technol, Dept Biomed Engn, Melbourne, FL 32901 USA
[2] Florida Inst Technol, Dept Chem, Melbourne, FL 32901 USA
[3] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA
基金
美国国家科学基金会;
关键词
thernostic; vascular tissue engineering; carbon monoxide; drug delivery; electrospinning; BYPASS; INHIBITION; NANOFIBERS; DISEASE;
D O I
10.1088/1748-6041/11/2/025009
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Hyper-proliferation of smooth muscle cells (SMCs) and a reduction in endothelial cell function are reasons for poor patency rates of current tissue engineered small-diameter vascular grafts. The controlled delivery of carbon monoxide (CO), a gasotransmitter involved in cell signaling, could improve vascular cell function in these grafts. Current CO releasing molecules (CORMs) can improve endothelialization of injured vessels with appropriate doses, but they still have limitations. The goal of this project was to generate a novel tissue engineered scaffold that includes a non-toxic and photoactivatable CORM. This is the first use of a CORM for tissue engineering. The results demonstrated that CORM-loaded, electrospun poly(epsilon-caprolactone) scaffolds can be photoactivated and release CO. The fluorescence that develops after CO release can be used to non-destructively track the extent of reaction. Further, activation can occur when both dry and incubated in cell culture conditions. However, incubation in serum protein-containing media decreases the time frame for activation, demonstrating the importance of testing the release profile in culture conditions. Rat SMCs were able to attach, grow, and express contractile SMC markers on activated CORM-loaded meshes and controls. Overall, these findings demonstrate that CORM-loaded electrospun scaffolds provide a promising delivery system for vascular tissue engineering.
引用
收藏
页数:10
相关论文
共 35 条
[1]   Meta-analysis of alternate autologous veinn bypass grafts to infrapopliteal arteries [J].
Albers, M ;
Romiti, M ;
Brochado-Neto, FC ;
Pereira, CAB .
JOURNAL OF VASCULAR SURGERY, 2005, 42 (03) :449-455
[2]  
Bashur CA, 2013, TISSUE ENG PT A, V19, P809, DOI [10.1089/ten.tea.2012.0309, 10.1089/ten.TEA.2012.0309]
[3]   Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assembly [J].
Bashur, Chris A. ;
Ramamurthi, Anand .
JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 2012, 6 (09) :673-686
[4]   Bench-to-bedside review: Carbon monoxide - from mitochondrial poisoning to therapeutic use [J].
Bauer, Inge ;
Pannen, Benedikt H. J. .
CRITICAL CARE, 2009, 13 (04)
[5]   Effect of electrospinning parameters on the nanofiber diameter and length [J].
Beachley, Vince ;
Wen, Xuejun .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2009, 29 (03) :663-668
[6]   Investigation of light-triggered carbon monoxide release from two manganese photoCORMs by IR, UV-Vis and EPR spectroscopy [J].
Berends, Hans-Martin ;
Kurz, Philipp .
INORGANICA CHIMICA ACTA, 2012, 380 :141-147
[7]   Light-triggered CO release from nanoporous non-wovens [J].
Bohlender, Carmen ;
Glaeser, Steve ;
Klein, Moritz ;
Weisser, Juergen ;
Thein, Susanne ;
Neugebauer, Ute ;
Popp, Juergen ;
Wyrwa, Ralf ;
Schiller, Alexander .
JOURNAL OF MATERIALS CHEMISTRY B, 2014, 2 (11) :1454-1463
[8]   EVALUATION OF THE ANTIMUTAGENIC POTENTIAL OF ANTHRACENE - IN-VITRO AND EX-VIVO STUDIES [J].
BUABBAS, A ;
IOANNIDES, C ;
WALKER, R .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1994, 309 (01) :101-107
[9]   Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors [J].
Chlopicki, Stefan ;
Lomnicka, Magdalena ;
Fedorowicz, Andrzej ;
Grochal, Elzbieta ;
Kramkowski, Karol ;
Mogielnicki, Andrzej ;
Buczko, Wodzimierz ;
Motterlini, Roberto .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (06) :641-650
[10]  
Go AS, 2014, CIRCULATION, V129, P399, DOI 10.1161/01.cir.0000442015.53336.12